Is RCUS stock safe? | Glauxie AI

Q: Is RCUS stock safe?

Arcus Biosciences, Inc. (RCUS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Terry J. Rosen. Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b... Employees: 200,000.

Q: What are the risks of investing in RCUS?

Identify key risks of investing in RCUS — debt, competition, volatility, and sector headwinds.

Q: Is RCUS a good long-term investment?

Evaluate RCUS as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does RCUS have?

Review RCUS total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is RCUS stock safe?

🦉

Arcus Biosciences, Inc. (RCUS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOTerry J. Rosen

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1...

Key Executives

Name	Title
Alexander Azoy	Chief Accounting Officer
Carolyn C. Tang	General Counsel & Corporate Secretary
Holli Kolkey	Vice President of Corporate Communications
Jennifer A. Jarrett	Advisor
Jonathan Yingling	Chief Scientific Officer
Juan Carlos Jaen	Co- Founder & President

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

RCUS Profile Financials

What are the risks of investing in RCUS? Is RCUS a good long-term investment? How much debt does RCUS have?